Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
Featured Clinical Study A Dual Phase 1/2, Investigator Initiated Study to Determine the Maximum Tolerated Dose, Safety, and Efficacy of 186Rhenium Nanoliposomes (186RNL) in Recurrent Glioma (CTRC# 12-02) Study Sponsor:
Featured Clinical Study A Dose Escalation and Expansion Study of Sonodynamic Therapy With SONALA-001 in Combination With Exablate 4000 Type-2 MR-guided Focused Ultrasound in Patients With Recurrent or Progressive Glioblastoma
Featured Clinical Study A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER) Study Sponsor: Boston Scientific Study website: Frontier Study
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects Featured Clinical Study Study to Evaluate the Safety, Tolerability, and Optimal Dose
Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study).
Always free for patients & caregivers
Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor
Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.
